LionsGate Technologies/Predictive Health Analytics files for $2.4M IPO on CSE

Photo of author

By Ted Liu

Predictive Health Analytics Inc. has filed a preliminary prospectus in connection with a proposed initial public offering (IPO). The company plans to issue up to 8 million common shares priced at $0.30 per share for gross proceeds of up to $2.4 million.

Predictive Health Analytics has applied to list its common shares at the Canadian Securities Exchange (CSE).

Mackie Research Capital Corp. acts as the agent for the offering. Beadle Raven LLP and Miller Thomson LLP act as legal counsel for Predictive Health Analytics and the agent respectively.

The prospectus will also qualify the distribution of 35 million shares issued in connection with the acquisition of LionsGate Technologies, Inc.

Incorporated in 2017, Predictive Health Analytics Inc. does not currently have an active business. It has entered into the definitive agreement with LionsGate or the acquisition of 100% of all the issued and outstanding shares of LionsGate for the purchase price of 35 million common shares at a deemed price of $0.30 per share with an aggregate deemed value of $10.5 million.

Founded in March 2012, Victoria, BC based LionsGate is a mHealth monitoring technology business. Together with its wholly owned subsidiary, LGT Medical, LionsGate operates under the business trade name of “LGT”.

photo credit: LionsGate Technologies